Analyst Ratings for Corbus Pharmaceuticals (CRBP)
CRBP Rating Summary
CRBP Price Target Summary
- Highest: $53.00 (RBC Capital)
- Lowest: $33.00 (Jefferies)
- Average: $45.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.43 (+450%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$45.43 (+450%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/28/2026 | Guggenheim | Paul Jeng | New Coverage | Buy (N/A) |
45.00 (N/A) |
10.08 (8.26) |
-18.06% | Details |
| 2/28/2025 | William Blair | Andy Hsieh | New Coverage | Outperform (N/A) |
N/A (N/A) |
7.47 (8.26) |
10.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
